Rispolept® (risperidone)

04.09.2013 Updated 22.10.2019 6759 views

By MoH of Ukraine order No. 771 of 02.09.13, the package insert (hereinafter, the insert) was approved for the original (reference) medicinal product containing risperidone, namely Rispolept®, oral solution, with amendments and additions to the following sections of the insert: "Indications," "Contraindications," "Method of administration and doses," "Adverse reactions," "Use during pregnancy or breastfeeding," "Children," "Special warnings and precautions for use," "Interaction with other medicinal products and other forms of interaction."